Sparian Biosciences is a biopharmaceutical company.
Sparian Biosciences has raised $15.0M in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Sparian Biosciences's investors include National Institutes of Health, National Institute on Drug Abuse (NIDA).
Sparian Biosciences is headquartered in New York, United States.
Sparian Biosciences is a biopharmaceutical company.
Sparian Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sparian Biosciences — Funding & Investors." VCBacked, April 9, 2026, https://www.vcbacked.co/company/sparian-biosciences. Accessed July 20, 2026.
VCBacked. (2026). Sparian Biosciences — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/sparian-biosciences
{{cite web |title=Sparian Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/sparian-biosciences |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated